Christophe Douat
Amministratore Delegato presso MEDINCELL S.A.
Patrimonio netto: 9 M $ in data 30/06/2024
Profilo
Christophe Douat is the founder and Chief Executive Officer of MedinCell SA, which was founded in 2003.
He is also the founder of Matignon Technologies II FCPR.
Currently, he holds the position of Chairman at Great North SARL and Director at CM Biomaterials BV.
In the past, he has held positions such as Director-Stakes at Matignon Investissement et Gestion SAS from 2001 to 2010, Director at Arterial Remodelling Technologies SA, Director at Groupement International d'Informatique de Santé SA, and Member-Supervisory Board at Nanobiotix SA from 2011 to 2017.
He was also a General Manager at Sabourin Lake Lodge from 1992 to 1997 and a Venture Partner at Matignon Technologies from 2001 to 2009.
Mr. Douat has a graduate degree from the University of Minnesota, an MBA from the University of Calgary, and an undergraduate degree from École Nationale Supérieure des Mines de Paris.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
MEDINCELL SA
2.24% | 31/03/2023 | 652 916 ( 2.24% ) | 9 M $ | 30/06/2024 |
Posizioni attive di Christophe Douat
| Società | Posizione | Inizio |
|---|---|---|
| MEDINCELL S.A. | Amministratore Delegato | 09/01/2003 |
| Great North SARL | Presidente | - |
CM Biomaterials BV
 CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Christophe Douat
| Società | Posizione | Fine |
|---|---|---|
| NANOBIOTIX | Direttore/Membro del Consiglio | 01/01/2017 |
Matignon Investissement et Gestion SAS
 Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Investitore di Private Equity | 01/05/2010 |
| Matignon Technologies | Corporate Officer/Principal | 01/04/2009 |
| NANOBIOTIX | Direttore/Membro del Consiglio | 01/01/2009 |
| Sabourin Lake Lodge | Corporate Officer/Principal | 01/01/1997 |
Formazione di Christophe Douat
| École Nationale Supérieure des Mines de Paris | Undergraduate Degree |
| University of Minnesota | Graduate Degree |
| University of Calgary | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NANOBIOTIX | Health Technology |
| MEDINCELL S.A. | Health Technology |
| Aziende private | 8 |
|---|---|
Matignon Investissement et Gestion SAS
Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Finance |
Arterial Remodelling Technologies SA
 Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Health Technology |
| Great North SARL | |
Groupement International d'Informatique de Santé SA
 Groupement International d'Informatique de Santé SA Publishing: Books/MagazinesConsumer Services Groupement International d'Informatique de Santé SA engages in the management of an online health and nutrition portal. Its services include daily effectiveness index, weekly synthesis, dietitian consultation, LeDiet community, practical tools, and chef and LeDiet recipes. The company was founded on October 9, 1986 and is headquartered in Paris, France. | Consumer Services |
CM Biomaterials BV
CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Producer Manufacturing |
| Sabourin Lake Lodge | |
| Matignon Technologies | |
Matignon Technologies II FCPR
 Matignon Technologies II FCPR Investment ManagersFinance Matignon Technologies II FCPR invests in early to later-stage companies mostly located in France and the European Union. It focuses on companies in the medical field or in the information technology sectors with revenues below €50 million. It invests between €500,000 and €10 million from early stage to growth operations. | Finance |
- Borsa valori
- Insiders
- Christophe Douat
